Treatment of MetS rats with AM6545 or AM4113 (10 mg/kg) significantly decreased TNF-α by 24% and 46%, respectively, and IL-6 by 24% and 37%, respectively (P < 0.05). Here, IL6 is linked to metabolic syndrome.